Beam Therapeutics BEAM Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's total operating expenses?
- Beam Therapeutics (BEAM) reported total operating expenses of $138.95M in Q1 2026.
- How has Beam Therapeutics's total operating expenses changed year-over-year?
- Beam Therapeutics's total operating expenses increased by 9.6% year-over-year, from $126.76M to $138.95M.
- What is the long-term trend for Beam Therapeutics's total operating expenses?
- Over 4 years (2021 to 2025), Beam Therapeutics's total operating expenses has grown at a 4.2% compound annual growth rate (CAGR), from $444.31M to $523.44M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.